Annovis Bio Inc (ANVS)
5.33
-0.06
(-1.11%)
USD |
NYSE |
May 07, 13:32
Annovis Bio Shares Outstanding: 11.01M for March 26, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
March 26, 2024 | 11.01M |
March 22, 2024 | 11.01M |
March 21, 2024 | 10.69M |
March 19, 2024 | 10.69M |
March 15, 2024 | 10.58M |
January 30, 2024 | 10.58M |
December 31, 2023 | 10.52M |
November 06, 2023 | 10.26M |
September 30, 2023 | 9.012M |
August 11, 2023 | 9.012M |
June 30, 2023 | 9.012M |
May 08, 2023 | 9.005M |
April 24, 2023 | 9.005M |
March 31, 2023 | 8.217M |
March 30, 2023 | 8.217M |
December 31, 2022 | 8.164M |
November 04, 2022 | 8.164M |
September 30, 2022 | 8.164M |
August 05, 2022 | 8.164M |
June 30, 2022 | 8.164M |
May 02, 2022 | 8.164M |
April 06, 2022 | 8.164M |
March 31, 2022 | 8.164M |
March 01, 2022 | 8.164M |
December 31, 2021 | 8.101M |
Date | Value |
---|---|
November 01, 2021 | 8.101M |
September 30, 2021 | 8.101M |
July 26, 2021 | 8.101M |
June 30, 2021 | 8.091M |
May 26, 2021 | 7.947M |
May 23, 2021 | 6.947M |
May 21, 2021 | 6.947M |
May 04, 2021 | 6.947M |
April 08, 2021 | 6.947M |
March 31, 2021 | 6.947M |
March 01, 2021 | 6.947M |
February 26, 2021 | 6.906M |
January 29, 2021 | 6.906M |
December 31, 2020 | 6.892M |
November 02, 2020 | 6.892M |
September 30, 2020 | 6.872M |
July 28, 2020 | 6.867M |
June 30, 2020 | 6.867M |
April 30, 2020 | 6.860M |
April 09, 2020 | 6.846M |
March 31, 2020 | 6.846M |
March 23, 2020 | 6.846M |
January 29, 2020 | 6.518M |
January 21, 2020 | 5.927M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
5.927M
Minimum
Jan 21 2020
11.01M
Maximum
Mar 22 2024
8.132M
Average
8.101M
Median
Jul 26 2021
Shares Outstanding Benchmarks
FibroGen Inc | 98.77M |
Cerus Corp | 184.89M |
OPKO Health Inc | 696.99M |
Stereotaxis Inc | 82.13M |
SINTX Technologies Inc | 122.68M |